ALS drug trial pulled before it even started
Disease control
Terminated
This study aimed to test whether a drug called RNS60, given as a mist through a nebulizer, could help people with amyotrophic lateral sclerosis (ALS). The trial was planned for about 140 adults with ALS, but it was withdrawn before any participants were enrolled. No results are a…
Phase: PHASE2 • Sponsor: Revalesio Corporation • Aim: Disease control
Last updated May 15, 2026 11:53 UTC